Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SEPA Pain & Spine is a leading interventional pain management practice based in Southeastern Pennsylvania, providing specialized care for chronic and acute pain conditions for over 25 years. The company offers a comprehensive range of treatments, including minimally invasive spine surgery, regenerative medicine through its partnership with Regenexx, and advanced therapies such as spinal cord stimulation and ketamine infusions. With multiple clinical locations and surgical centers, the practice focuses on delivering patient-centered, high-quality care for indications like arthritis, fibromyalgia, and complex spinal disorders. In March 2026, SEPA Pain & Spine was acquired by DxTx Pain & Spine, a national network of pain management providers, to further enhance its operational capabilities and patient reach.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on S.E. PA Pain Management.